Out of the bitter came forth sweet

Enhanced antitumor activity mediated by human 4-1BB-engineered T cells

(2013) Inbal Daniel-Meshulam et al.   INTERNATIONAL JOURNAL OF CANCER

Human T Cells Engineered To Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity

(2013) C. Ankri et al.   JOURNAL OF IMMUNOLOGY

Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models

(2012) J. H. Shin et al.   BLOOD

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

(2012) Suzanne L Topalian et al.   CURRENT OPINION IN IMMUNOLOGY

T cell exhaustion

(2011) E John Wherry   NATURE IMMUNOLOGY

Genetically modulating T-cell function to target cancer

(2011) Efrat Merhavi-Shoham et al.   SEMINARS IN CANCER BIOLOGY

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology

The complex role of B7 molecules in tumor immunology

(2008) Barbara Seliger et al.   TRENDS IN MOLECULAR MEDICINE